Clinical trials
Recruiting Phase 1/2 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 15 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 7 |
| GlaxoSmithKline | 4 |
| Hoffmann-La Roche | 4 |
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 3 |
| AbbVie | 2 |
| BioInvent International AB | 2 |
| BioNTech SE | 2 |
| Bristol-Myers Squibb | 2 |
| MediLink Therapeutics (Suzhou) Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Recurrence | 7 |
| Endometrial Neoplasms | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Multiple Myeloma | 4 |
| Neoplasm Metastasis | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Prostatic Neoplasms, Castration-Resistant | 3 |
| Small Cell Lung Carcinoma | 3 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.